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Introduction: Diabetes mellitus (DM) is a clinical syndrome characterized by hyperglycemia
due to absolute or relative insulin deficiency. Cardiovascular autonomic neuropathy in-
vokes potentially life threatening outcomes especially in poorly controlled diabetic pa-
tients. However, there is scarcity of epidemiological data for CAN in poorly controlled type
2 diabetic patients in Pakistan.
Objective: The objective of this study is to assess the frequency of cardiovascular autonomic
neuropathy (CAN) in patients with poorly controlled type 2 diabetes mellitus in Pakistan.
Study design: Descriptive cross-sectional.
Setting: Department of Medicine, Liquate University Hospital, Hyderabad/Jamshoro, Sindh,
Pakistan.
Duration: February to November 2012.
Sampling technique: Non-probability purposive.
Material and method: This study included 207 patients, who all met the inclusion criteria and
gave an informed consent for inclusion in the study. All the patients in the study were
evaluated for CAN using four different clinical tests- Resting heart rate, test for orthostatic
hypotension, hand gripping test and QTc interval on ECG. Resting Heart Rate of more than
100 beats per minute was taken as abnormal. Orthostatic hypotension was defined as a fall
of systolic blood pressure >20 mmHg and/or diastolic blood pressure >10 mmHg on change
of posture. The patients were asked to squeeze a small ball in hand gripping test and an
increase in diastolic blood pressure <15 mmHg was considered abnormal. ECG recording
with QTc interval >440 ms was considered abnormal or prolonged. Patients were labeled as
CANþve if any two ormore than two of the above listed testswere found positive/abnormal.
Results: In our study, 76 out of 207 (36.7%) of the patients with poorly controlled type 2
diabetes mellitus were found to have cardiovascular autonomic neuropathy (CAN).
Conclusion: Cardiac autonomic dysfunctions are common in poorly controlled type 2
diabetes.
Copyright © 2014, Cardiological Society of India. All rights reserved.om, imran6naili@hotmai
ociety of India. All rightsl.com (N. Masood).
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Cardiovascular autonomic neuropathy (CAN) is one of the
more often overlooked, but serious complications of diabetes.
This is largely owing to the fact that very little information on
epidemiology of CAN in diabetic populations from Pakistan is
available. Furthermore, heterogeneous methodology of avail-
able epidemiological studies from this regionmakes it difficult
to compare date from the available studies.
Available studies have highlighted a variety of factors to be
associated with CAN and indicate that its prevalence in-
creases with age of diabetic patient, duration of diabetes, and
poor glycemic control.1 CAN also co-exists with distal sym-
metric polyneuropathy and microangiopathy of diabetes. Age
of the patient, duration of diabetes, obesity and smoking are
independent risk factors for reduced heart rate variability
(HRV) in type 2 diabetes.2 Another study concluded that
abnormal HbA1c levels, hypertension, distal symmetrical
polyneuropathy, retinopathy, and exposure to hyperglycemia
were risk factors for developing CAN in type 1 diabetes.3
Resting tachycardia and fixed heart rate are characteristic
late findings in diabetic patients with vagal impairment due to
CAN.4 Therefore, diabetic patients who are likely to have CAN
should be tested for cardiac stress test before undertaking an
exerciseprogram.5Theautonomicdysfunction impairsexercise
tolerance, reduces response to heart rate, blood pressure and
blunts the increased cardiac output in response to exercise.6
Diabetic patients also run a 2e3 folds higher risk of car-
diovascular morbidity and mortality during surgery.5 There is
an association between CAN and intraoperative hypothermia
and orthostatic hypotension, although the fall in blood pres-
sure may also be asymptomatic.7 The mechanisms by which
CAN causes increased mortality remains obscure and it is
often difficult to determine the independent effects of CAN on
intraoperative mortality because of the coexisting cardiovas-
cular disease (CVD). Two prospective studies have studied the
relationship between CAN and major intraoperative cardio-
vascular events. One potential cause of higher mortality dur-
ing surgery in such patients could be severe but asymptomatic
ischemia, which can induce lethal arrhythmias.8,9 Patients
with severe autonomic dysfunction also have a higher risk of
BP instability. Thus, intraoperative inotropic support is often
needed in patients with greater autonomic impairment.10
American Diabetes Association recommends yearly
screening for autonomic neuropathy in type 2 diabetes mel-
litus from the time of diagnosis.112. Materials and methods
This study included two hundred and seven (207) type 2 dia-
betes patients who attended medical wards and/or OPDs at
Liaquat University of Medical & Health Sciences Hospital
(LUMHS) Jamshoro/Hyderabad, Sindh, Pakistan. All the pa-
tients from either sex whomet the following inclusion criteria
were considered for inclusion in this study.
1. Age above 30 years
2. S. HbA1c 7 % 11.5%Patients meeting the following exclusion criteria were
excluded from the study:
1. Patients with hypotension, Congestive cardiac failure,
Ischemic heart Disease, Hyperthyroidism, Chronic renal
failure
2. Patients on medications such as Vasodilators, Diuretics,
Anti-arrhythmic, Beta-blockers, Alpha-agonist or Alpha-
blockers
An informed consent for inclusion in this study was ob-
tained from all the patients. We used non-probability purpo-
sive sampling technique for this study. All patients were fully
explained about the different maneuvers like hand grip,
standing and squeeze of ball. The recruited patients were
tested for
1. Resting heart rate- A resting heart rate of more than 100
beats per minute considered abnormal.
2. Orthostatic hypotension e Blood pressure was first
measured (using the aneroid sphygmomanometer) in su-
pine position and then the patient was instructed to stand
up. Blood pressure was again measured after 2 min of
standing. A fall in systolic blood pressure of >20 mmHg
and/or in diastolic blood pressure >10 mmHg was consid-
ered abnormal.
3. Hand gripping test e The blood pressure of the patient was
first measured in supine position. The patient was
instructed to squeeze a small ball in his/her hand for about
5 min while lying in the bed and then his/her blood pres-
sure was measured (using the aneroid sphygmomanom-
eter) again. An increase in diastolic blood pressure
<15 mmHg was considered abnormal.
4. ECG recording-QTc interval >440 or prolonged ms was
considered abnormal.
If the findings on any two or more of the above tests in a
patient were abnormal, the patient was diagnosed as positive
for CAN.
Data was entered and analyzed by SPSS version 16. The
frequencies and percentages were calculated for qualitative
variables such as gender and age group and chi-square test
was used to compare the proportions. Mean ± SD was calcu-
lated for numerical variables like age in years, pulse rate
(lying/supine, standing), blood pressure (lying/supine, stand-
ing and after hand griping), QTc interval, random blood sugar
level (RBS) and HbA1c. All the data was analyzed for a 94%
confidence interval. A p-value 0.05 was considered as sta-
tistically significant.3. Results
A total of 207 type 2 diabetic patients fulfilling the inclusion
criteria were included in this study. The mean age of these
patients was 54.6 ± 7.8 years. Out of 207 patients, 80 (38.6%)
aged between 41 and 50 years, 75 (36.2%) were between 31 and
40 years old and 50 (24.2%) were between 51 and 60 years old.
Please see Table 1 below for full age-wise distribution of the
study population.
Table 1 e Distribution of age (n ¼ 207).
n %
Gender
Male 107 51.7
Female 100 48.3
Age group (Yrs)
31e40 75 36.2
41e50 80 38.6
51e60 50 24.2
61 2 0.9
Mean ± SD 54.6 ± 7.8
Table 3 e Distribution of age by CAN.
Age 31e40
(%)
41e50
(%)
51e60
(%)
61
(%)
p value
Diabetics
with CAN
20 (26.3) 25 (32.9) 30 (39.4) 1 (1.3) <0.04
Diabetics
without CAN
76 (58.0) 35 (26.7) 19 (14.5) 1 (0.8)
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tients in the study group with an average weight of
75.0 ± 15.1 kg and mean HbA1c level of 7.9 ± 4.2%. The mean
blood pressure in the studied patients was found to be
133.3 ± 26.4 mmHg and the mean random blood sugar level
was 170.1 ± 62.5 mg/dl. A total of 76 (36.7%) patients were
found to have cardiovascular autonomic neuropathy (CAN)
based on the diagnostic protocol described above. The mean
QTc interval was 490.8± 22.3 (m sec), as given in Table 2 below.
There was no statistically significant difference in inci-
dence of CAN among patients belonging to two genders
(p > 0.17). However, a statistically significant difference in
incidence of CAN was observed when comparing occurrence
of CAN in different age groups (p < 0.04), as given in Table 3
below.4. Discussion
Our analysis revealed that a total of 76 (36.7%) patients with
type 2 diabetes mellitus had cardiovascular autonomic neu-
ropathy (CAN). It further revealed that there were no signifi-
cant differences between incidences of CAN between two
sexes, but the difference in incidence between different age
groups was significant.
In another descriptive study from Hyderabad, Pakistan,
researchers found the incidence of definitive and borderline
CAN in patients with type 2 diabetes mellitus to be 30% and
40% respectively, which was very similar to our findings. The
researchers observed that intensive glycemic control is asso-
ciated with a better cardiac autonomic nerve functions. Mean
age of the patient in their study was 53.62 ± 8.30 years with
male to female ratio of 1:1, a finding again very similar to ours.
Mean duration of diabetes at the time of diagnosiswas 14 ± 3.5
years and mean HbA1c level was 11.36 ± 3.6 mg/dl indicating
very bad glycemic control in the studied population. The re-
searchers concluded that variability of heart rate withTable 2 e Distribution of diabetic patients by CAN
(n ¼ 207).
Number of abnormal test 220
Random blood sugar (RBS mg/dl) 170.1 ± 62.5
QTc (m sec) 490.8 ± 22.3
CAN positive CAN negative
Males 44 (57.8) 63 (48.1)
Females 32 (42.1) 68 (51.9)
p value 0.17respiration was significantly related to duration but not to the
control of diabetes (p < 0.05). QTc showed a statistically sig-
nificant correlation with the known duration of diabetes and
heart rate variability with respiration (p < 0.05).12
In another cross sectional study to determine the preva-
lence and risk factors for cardiac autonomic neuropathy (CAN)
among 100 patients with type 1 and type 2 diabetes mellitus,
using five autonomic function tests by Eving's methodology,
researchers found the incidence of CAN to be 60%. Univariate
analysis showed a significant association between CAN and
higher age (odds ratio (OR) 15.75), prolongation of QTc (OR
5.55), duration of disease over 10 years (OR 2) and peripheral
neuropathy (< 0.001) in patients with type 1 diabetes. Signifi-
cant risks factors for CAN among patients with type 2 diabetes
included coexistent peripheral neuropathy (OR 14), prolonged
QTc (OR 9.75), higher age (OR 7.2) and disease duration over 10
years (OR 1.92) in univariate analysis, but none of these factors
showed independent risk in multivariate analysis. The Dis-
ease duration over 10 years resulted in QTc prolongation in a
significant numbers of cases with type 1 and type 2 diabetes.13
In our study, we found a strong correlation between occur-
rence of CAN and widening of QTc interval and age at diag-
nosis. However, we found no significant correlation between
gender and incidence of CAN.
Other researchers have studies to detect other useful in-
dicators for diagnosing CAN. Another study described the
usefulness of heart rate variability (HRV) and complexity an-
alyses from short term ECG recordings as a screening tool for
CAN. A total of 17 sets of ECG recordings taken from diabetic
subjects with and without CAN performed in resting supine
position were evaluated. The study demonstrated the poten-
tial utility of SampEn (a complexity based estimator) of HRV in
identifying asymptomatic CAN.14 Another study evaluated the
impact of parental type 2 diabetes on the autonomic nervous
system of non-diabetic offspring. The study attempted to
determine if the evaluated non-diabetic subjects with parents
having type 2 diabetes had, autonomic neuropathy and if
autonomic neuropathy in these subjects was associated with
changes in 24-h ambulatory blood pressure (AMBP) and uri-
nary albumin excretion rate (UAER). The study examined 223
non-diabetic offspring of type 2 diabetic subjects and a control
group of 258 offspring of non-diabetic subjects. The preva-
lence of autonomic neuropathy in the non-diabetic offspring
with parental type 2 diabetes (6.7%) was significantly higher
compared with the control group (1.6%). Autonomic neurop-
athy in such subjects was also found to be associated with a
higher fasting insulin level, higher UAER, higher 24-h mean
AMBP and reduced diurnal blood pressure variation after
adjustment for age, sex, and BMI. In conclusion, parental type
2 diabetes was found to be associated with alterations in the
autonomic nervous system in non-diabetic subjects.15
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of CAN in type 2 diabetes mellitus and to correlate CAN with
retinopathy, microalbuminuria and glycated haemoglobin
levels. The results of this study revealed that 54% of studied
patients had CAN. Furthermore, the researchers found that
52% patients had parasympathetic neuropathy, 20% had
sympathetic neuropathy and 28% had two abnormal cardio-
vascular reflexes. The researchers also observed micro-
albuminuria and retinopathy in 36% and 10% of these patients
respectively.16 The percentage of CAN in our study was
comparatively lesser than the above study. This difference in
results may be due to operational definitions and further
classification of CAN into different groups. Autonomic neu-
ropathy is a serious complication of diabetes mellitus.
Another study found the prevalence of CAN among dia-
betic patients to be 51.9%. The prevalence of sympathetic and
parasympathetic CAN was 28.9% and 44% respectively. These
researchers also noted a significant different in the incidence
of CAN between type 1 and type 2 diabetic patients.17
The postural drop in blood pressure caused by autonomic
neuropathy in diabetes mellitus is regarded as a risk factor for
cardiovascular disease. A study was conducted in a tertiary
care hospital of Peshawar to assess the prevalence of ortho-
static hypotension in diabetic patients and to find its corre-
lation with hypertension in patients with diabetes mellitus.
Two hundred indoor diabetic patientswere assessed; of which
26% were found to have orthostatic hypotension.185. Conclusion
The cardiac autonomic neuropathy is common in diabetic
patients in Pakistan. The clinician should identify early CAN
by doing simple tests. This study also demands for large scale
population based studies in future.Conflicts of interest
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